Smoking during pregnancy and intention to quit: A profile of methadone-maintained women

Nancy A. Haug, Maxine L Stitzer, Dace S. Svikis

Research output: Contribution to journalArticle

Abstract

The present study characterized cigarette smoking patterns (self-report, carbon monoxide, and cotinine), health-risk perceptions, attitudes, and quitting intentions among pregnant methadone-maintained women (n = 50) enrolled in comprehensive perinatal drug treatment. At baseline, women expressed only moderate motivation and self-efficacy for smoking cessation, and 60% were in the precontemplation stage of change for quitting. Follow-up assessment during pregnancy (n = 40) showed no change in self-reported cigarettes per day or cotinine values. Despite recognition of the personal and fetal health risks of smoking and high social support for quitting, none of the women stopped smoking and few demonstrated reduction. Compared to other pregnant smokers, this sample is characterized by many of the factors associated with difficulty in quitting. Innovative harm-reduction strategies and nicotine replacement medications deserve scientific attention in this high-risk group of tenacious smokers.

Original languageEnglish (US)
Pages (from-to)333-339
Number of pages7
JournalNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Volume3
Issue number4
DOIs
StatePublished - 2001

Fingerprint

Methadone
Cotinine
Smoking
Pregnancy
Harm Reduction
Health
Smoking Cessation
Self Efficacy
Carbon Monoxide
Nicotine
Tobacco Products
Social Support
Self Report
Motivation
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

@article{f08b2c805b0a4ed28a7cfe19a336a153,
title = "Smoking during pregnancy and intention to quit: A profile of methadone-maintained women",
abstract = "The present study characterized cigarette smoking patterns (self-report, carbon monoxide, and cotinine), health-risk perceptions, attitudes, and quitting intentions among pregnant methadone-maintained women (n = 50) enrolled in comprehensive perinatal drug treatment. At baseline, women expressed only moderate motivation and self-efficacy for smoking cessation, and 60{\%} were in the precontemplation stage of change for quitting. Follow-up assessment during pregnancy (n = 40) showed no change in self-reported cigarettes per day or cotinine values. Despite recognition of the personal and fetal health risks of smoking and high social support for quitting, none of the women stopped smoking and few demonstrated reduction. Compared to other pregnant smokers, this sample is characterized by many of the factors associated with difficulty in quitting. Innovative harm-reduction strategies and nicotine replacement medications deserve scientific attention in this high-risk group of tenacious smokers.",
author = "Haug, {Nancy A.} and Stitzer, {Maxine L} and Svikis, {Dace S.}",
year = "2001",
doi = "10.1080/14622200110050493",
language = "English (US)",
volume = "3",
pages = "333--339",
journal = "Nicotine and Tobacco Research",
issn = "1462-2203",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Smoking during pregnancy and intention to quit

T2 - A profile of methadone-maintained women

AU - Haug, Nancy A.

AU - Stitzer, Maxine L

AU - Svikis, Dace S.

PY - 2001

Y1 - 2001

N2 - The present study characterized cigarette smoking patterns (self-report, carbon monoxide, and cotinine), health-risk perceptions, attitudes, and quitting intentions among pregnant methadone-maintained women (n = 50) enrolled in comprehensive perinatal drug treatment. At baseline, women expressed only moderate motivation and self-efficacy for smoking cessation, and 60% were in the precontemplation stage of change for quitting. Follow-up assessment during pregnancy (n = 40) showed no change in self-reported cigarettes per day or cotinine values. Despite recognition of the personal and fetal health risks of smoking and high social support for quitting, none of the women stopped smoking and few demonstrated reduction. Compared to other pregnant smokers, this sample is characterized by many of the factors associated with difficulty in quitting. Innovative harm-reduction strategies and nicotine replacement medications deserve scientific attention in this high-risk group of tenacious smokers.

AB - The present study characterized cigarette smoking patterns (self-report, carbon monoxide, and cotinine), health-risk perceptions, attitudes, and quitting intentions among pregnant methadone-maintained women (n = 50) enrolled in comprehensive perinatal drug treatment. At baseline, women expressed only moderate motivation and self-efficacy for smoking cessation, and 60% were in the precontemplation stage of change for quitting. Follow-up assessment during pregnancy (n = 40) showed no change in self-reported cigarettes per day or cotinine values. Despite recognition of the personal and fetal health risks of smoking and high social support for quitting, none of the women stopped smoking and few demonstrated reduction. Compared to other pregnant smokers, this sample is characterized by many of the factors associated with difficulty in quitting. Innovative harm-reduction strategies and nicotine replacement medications deserve scientific attention in this high-risk group of tenacious smokers.

UR - http://www.scopus.com/inward/record.url?scp=0035180350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035180350&partnerID=8YFLogxK

U2 - 10.1080/14622200110050493

DO - 10.1080/14622200110050493

M3 - Article

C2 - 11694200

AN - SCOPUS:0035180350

VL - 3

SP - 333

EP - 339

JO - Nicotine and Tobacco Research

JF - Nicotine and Tobacco Research

SN - 1462-2203

IS - 4

ER -